If you need more lookups,
subscriptions start at $34 USD/month.
Kevin Webster Location
Boston, MA, US
Kevin Webster Work
Chief Science Officer @ (June 2019 - Present)
Sr. Vice President Cancer Biology @ Effector Therapeutics (June 2014 - June 2019)
Founder and President @ Partners In Innovation, LLC (January 2013 - June 2014)
Vice President Oncology @ (January 2010 - May 2013)
Executive Director Cancer Bioscience @ (November 2005 - January 2010)
Global Product Director @ (August 2006 - February 2007)
Director Cancer Bioscience @ (December 2001 - November 2005)
Associate Director Oncology Drug Discovery @ (January 1991 - January 2001)
Kevin Webster Education
Yale University
PhD (Molecular Biophysics and Biochemistry)
1986-1991
Stony Brook University
Bachelor of Science (B.S.) (Biochemistry)
1982-1986
Kevin Webster Skills
Biochemistry
Bioinformatics
Biologics
Biomarker Discovery
Biomarkers
Biopharmaceuticals
Biotechnology
Cancer
Cancer Immunotherapy
Cell
Cell Biology
Chemistry
Clinical Development
Clinical Research
Clinical Trials
Drug Development
Drug Discovery
Drug Metabolism
Immunology
In Vitro
Life Sciences
Lifesciences
Medical Writing
Medicinal Chemistry
Molecular Biology
Oncology
Pharmaceutical Industry
Pharmacokinetics
Pharmacology
Protein Chemistry
Science
Strategic Partnerships
Target Identification
Technology Transfer
Translational Medicine
Marketing
Healthcare
Customer Service
Business Development
Cancer Biology
Microsoft Office
Kevin Webster Summary
Kevin Webster, based in Boston, MA, US, is currently a Chief Science Officer at Frontier Medicines. Kevin Webster brings experience from previous roles at Effector Therapeutics, Partners In Innovation, LLC and AstraZeneca. Kevin Webster holds a 1986 - 1991 PhD in Molecular Biophysics and Biochemistry @ Yale University. With a robust skill set that includes Biochemistry, Bioinformatics, Biologics, Biomarker Discovery, Biomarkers and more. Kevin Webster has 2 emails and 4 mobile phone numbers on RocketReach.
Looking for a different Kevin Webster?
Find contact details for 700 million professionals.